Terns Pharmaceuticals, Inc.
TERN
शेयरों में रैंक
#3544
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the... Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor agonist distinguished by its liver-specific distribution and non-bile acid properties, is presently undergoing Phase IIa clinical trials for NASH. TERN-201, a vascular adhesion protein-1 inhibitor, is in Phase Ib clinical studies, also targeting NASH. Terns is also progressing TERN-501, a thyroid hormone receptor beta agonist engineered for improved liver targeting and metabolic resilience, through Phase I clinical trials for NASH. Furthermore, the company is advancing TERN-601, an oral small-molecule Glucagon-Like Peptide-1 receptor agonist program, intended for the management of NASH and various metabolic conditions, including obesity. Established in 2016, Terns Pharmaceuticals maintains its corporate headquarters in Foster City, California.
शेयर मूल्य
$52.95
अंतिम समन्वयन: 2026-05-15
मार्केट कैप
$4.77B
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
550.49%
देश
US
व्यापार Terns Pharmaceuticals, Inc. (TERN)
श्रेणी
Healthcare
Terns Pharmaceuticals, Inc. (TERN) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $52.95 (2026-05-01 को)
दिन का सबसे निम्न समापन मूल्य: $20.53 (2021-02-01 को)
दिन का सबसे निम्न समापन मूल्य: $20.53 (2021-02-01 को)
Terns Pharmaceuticals, Inc. के स्टॉक मूल्य का इतिहास 2021 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
| वर्ष | प्रदर्शन |
|---|---|
| 2026 (TTM) | -0.60% |
| 2025 | 517.55% |
| 2024 | -2.74% |
| 2023 | -12.48% |
| 2022 | 13.79% |
| 2021 | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
| कंपनी | स्टॉक मूल्य | परिवर्तन 1व% | देश |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.63 | -3.92% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
